Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biosimilars and Biobetters

29 Sep 2014 - 30 Sep 2014 - London, UK



Bookmark and Share


The industry leading Biosimilars & Biobetters Conference for combining new biosimilars and biobetter developments with essential networking opportunities, will be taking place in London, on the 29th-30th of September 2014. 

With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.

Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding biosimilar commercial and manufacturing developments.

KEY TOPICS INCLUDE:

  • Optimizing the commercial potential of biosimilars in Europe 
  • The big guns are coming! ...how will the entry of originator companies impact the biosimilars industry 
  • What is on the horizon? ... Reviewing the opportunities and challenges for the biopharmaceutical industry 
  • Christening day…but what shall we call you! Discussing the ongoing debate on naming biosimilars... and much more!

KEY SPEAKERS INCLUDE:

  • Alan Sheppard, Global Head Generics, Thought Leadership, IMS Health 
  • Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals 
  • Uwe Gudat, Head of Safety Biosimilars, Merck Switzerland Limited 
  • Catherine Akers, Regulatory Affairs Manager, Amgen Inc  
  • Carsten Brockmeyer, Founder, Formycon AG 
  • Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, Medimmune (AstraZeneca Biologics) 
  • Ineke Braat, CEO, Pan-Generika 
  • Sharma Alok, Principal Scientist & Head Analytical Development, Lupin Laboratories Ltd 
  • Steinar Madsen, Medical Director, Norwegian Medicines Agency 
  • Peter Wittner, Senior Consultant, Interpharm Consultancy 
  • Sarah Faircliffe, Legal Director, Bird & Bird...

Plus, many more at this year's event.

For more information, contact Fateja Begum on +44 (0) 207 827 6184 or e-mail fbegum@smi-online.co.uk

For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk

Event website: www.smi-online.co.uk/2014biosimilars65.asp



Further information
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!